Inventor of
Method to screen, diagnose or monitor treatment using increased numbers of deviating analytes
Patent application(s)
WO2024200811
( 03 October 2024 )
Combinations of therapeutic agents for treating uveal melanoma
Patent application(s)
WO2020239685
( 03 December 2020 )
Inhibition of a lncRNA for treatment of neuroblastoma
Patent application(s)
WO2019149616
( 08 August 2019 )
Granted patent(s)
EP3746555
( 30 March 2022 )
Biomarkers for disease burden of neuroblastoma
Patent application(s)
WO2019115214
( 20 June 2019 )
Granted patent(s)
EP3724356
( 24 January 2024 )
Usages of recombinant extracellular vesicles
Patent application(s)
WO2019091964
( 16 May 2019 )
Granted patent(s)
EP3483588
( 06 November 2019 )
Inhibition of a lncRNA for treatment of melanoma
Patent application(s)
WO2015024986
( 26 February 2015 )
Granted patent(s)
USRE048801
( 02 November 2021 )
NEUROBLASTOMA PROGNOSTIC MULTIGENE EXPRESSION SIGNATURE
Patent application(s)
WO2010066851
( 17 June 2010 )
Granted patent(s)
EP2364369
( 29 July 2015 )